ID: ALA554505

Max Phase: Preclinical

Molecular Formula: C21H36ClN3O3S

Molecular Weight: 409.60

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1c2c(c(NC(=O)C(C)(C)C)c(C)c1NS(C)(=O)=O)N(CC(C)(C)C)CC2.Cl

Standard InChI:  InChI=1S/C21H35N3O3S.ClH/c1-13-15-10-11-24(12-20(3,4)5)18(15)17(22-19(25)21(6,7)8)14(2)16(13)23-28(9,26)27;/h23H,10-12H2,1-9H3,(H,22,25);1H

Standard InChI Key:  OOPIZGDWNHCJTO-UHFFFAOYSA-N

Associated Targets(Human)

THP-1 11052 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Acyl-CoA:cholesterol acyltransferase 1121 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 409.60Molecular Weight (Monoisotopic): 409.2399AlogP: 4.07#Rotatable Bonds: 4
Polar Surface Area: 78.51Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.14CX Basic pKa: 4.76CX LogP: 4.18CX LogD: 4.18
Aromatic Rings: 1Heavy Atoms: 28QED Weighted: 0.79Np Likeness Score: -0.92

References

1. Shoji Y, Takahashi K, Ohta M, Kasai M, Kunishiro K, Kanda M, Yogai S, Takeuchi Y, Shirahase H..  (2009)  Novel indoline-based acyl-CoA: cholesterol acyltransferase inhibitor: Effects of introducing a methanesulfonamide group on physicochemical properties and biological activities.,  17  (16): [PMID:19608421] [10.1016/j.bmc.2009.06.047]

Source